The epitope tagging is a procedure in which a known epitope is fused to a recombinant protein with the help of genetic engineering. Epitope tags helps to detect proteins when no antibody is available. This procedure can be used to characterize newly discovered proteins as well as the low abundant proteins.
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (V5, c-myc, HA, AU1, AU5, Cre, GFP, Glu- Glu, glutathione S-transferase, 6X HIS, MBP, S-Tag, RNA Polymerase TFIIB, Thioredoxin, VSV-G, Others), Application (Western Blot, Immunoprecipitation, Protein Purification, Flow Cytometry, Immunofluorescence Microscopy)-Industry Trends and Forecast to 2032.
.
The Global Epitope Tags Market size was valued at USD 2.89 USD Billion in 2024.
The Global Epitope Tags Market is projected to grow at a CAGR of 4.9% during the forecast period of 2025 to 2032.
The major players operating in the market include Epitope Biotech , Cell Biolabs , Merck KGaA, Abcam plc, Thermo Fisher Scientific, GenScript, NovoPro Bioscience , Abbiotec , Biogenuix.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
